Low immunogenic endothelial cells endothelialize the Left Ventricular Assist Device

Figueiredo, Constanca; Eicke, Dorothee; Yuzefovych, Yuliia; Avsar, Murat; Hanke, Jasmin Sarah; Pflaum, Michael; Schmitto, Jan-Dieter; Blasczyk, Rainer ORCID; Haverich, Axel; Wiegmann, Bettina

Low haemocompatibility of left ventricular assist devices (LVAD) surfaces necessitates anticoagulative therapy. Endothelial cell (EC) seeding can support haemocompatibility, however, the availability of autologous ECs is limited. In contrast, allogeneic ECs are readily available in sufficient quantity, but HLA disparities induce harmful immune responses causing EC loss. In this study, we investigated the feasibility of using allogeneic low immunogenic ECs to endothelialize LVAD sintered inflow cannulas (SIC). To reduce the immunogenicity of ECs, we applied an inducible lentiviral vector to deliver short-hairpins RNA to silence HLA class I expression. HLA class I expression on ECs was conditionally silenced by up to 70%. Sufficient and comparable endothelialization rates were achieved with HLA-expressing or HLA-silenced ECs. Cell proliferation was not impaired by cell-to-Sintered Inflow Cannulas (SIC) contact or by silencing HLA expression. The levels of endothelial phenotypic and thrombogenic markers or cytokine secretion profiles remained unaffected. HLA-silenced ECs-coated SIC exhibited reduced thrombogenicity. In contrast to native ECs, HLA-silenced ECs showed lower cell lysis rates when exposed to allogeneic T cells or specific anti-HLA antibodies. Allogeneic HLA-silenced ECs could potentially become a valuable source for LVAD endothelialization to reduce immunogenicity and correspondingly the need for anticoagulative therapy which can entail severe side effects


Citation style:

Figueiredo, Constanca / Eicke, Dorothee / Yuzefovych, Yuliia / et al: Low immunogenic endothelial cells endothelialize the Left Ventricular Assist Device. 2019.

Access Statistic

Last 12 Month:

open graphic


Use and reproduction: